# Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)

> **NCT01404923** · PHASE4 · COMPLETED · sponsor: **Laboratoires Mayoly Spindler** · enrollment: 436 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** anti spasmodic agents
- **DRUG:** alverine citrate, simeticone

## Key facts

- **NCT ID:** NCT01404923
- **Lead sponsor:** Laboratoires Mayoly Spindler
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404923, "Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01404923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*